Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jyothi K Mallajosyula"'
Autor:
Jyothi K Mallajosyula, Deepinder Kaur, Shankar J Chinta, Subramanian Rajagopalan, Anand Rane, David G Nicholls, Donato A Di Monte, Heather Macarthur, Julie K Andersen
Publikováno v:
PLoS ONE, Vol 3, Iss 2, p e1616 (2008)
Age-related increases in monoamine oxidase B (MAO-B) may contribute to neurodegeneration associated with Parkinson's disease (PD). The MAO-B inhibitor deprenyl, a long-standing antiparkinsonian therapy, is currently used clinically in concert with th
Externí odkaz:
https://doaj.org/article/b8482a61d62f4122afaf4ad8c7643b7a
Publikováno v:
Neurobiology of Disease, Vol 43, Iss 2, Pp 527-532 (2011)
We previously demonstrated that elevation of astrocytic monoamine oxidase B (MAO-B) levels in a doxycycline (dox)-inducible transgenic mouse model following 14 days of dox induction results in several neuropathologic features similar to those observe
Externí odkaz:
https://doaj.org/article/4caeb220f4bc40ec8bf4d585c9c26a38
Publikováno v:
Neurobiology of Disease, Vol 40, Iss 2, Pp 444-448 (2010)
We previously demonstrated that elevation of astrocytic monoamine oxidase B (MAO-B) levels in a doxycycline (dox)-inducible transgenic mouse model following 14 days of dox induction results in several neuropathologic features similar to those observe
Externí odkaz:
https://doaj.org/article/1dc1a0e789444e4e87db97fe7acbd9a5
Autor:
Jyothi K. Mallajosyula, Deepinder Kaur, Shankar J. Chinta, Subramanian Rajagopalan, Anand Rane, David G. Nicholls, Donato A. Di Monte, Heather Macarthur, Julie K. Andersen
Publikováno v:
PLoS ONE, Vol 7, Iss 8 (2012)
Externí odkaz:
https://doaj.org/article/8e4fe8fdf2ac4b2c99faddfd55c5ebaf
Publikováno v:
Neurobiology of Disease, Vol 43, Iss 2, Pp 526- (2011)
Externí odkaz:
https://doaj.org/article/aa586546f977440b8be077f1229db4a2
Autor:
Rachel Chikwamba, Alison A. McCormick, Jyothi K. Mallajosyula, Trushar Jeevan, Richard J. Webby
Publikováno v:
International Journal of Vaccine Research. 1:01-06
Recombinant subunit vaccines are an efficient strategy to meet the demands of a possible influenza pandemic, because of rapid and scalable production. However, vaccines made from recombinant Hemagglutinin (HA) subunit protein are often of low potency
Autor:
Payal D. Maharaj, Christopher M. Kearney, Alison A. McCormick, Yiyang Zhou, Jyothi K. Mallajosyula
Publikováno v:
Molecular Biotechnology. 57:325-336
We have developed a transencapsidated vaccine delivery system based on the insect virus, Flock House virus (FHV). FHV is attractive due to its small genome size, simple organization, and nonpathogenic characteristics. With the insertion of a Tobacco
Autor:
Gloria Lee, Christopher M. Kearney, Yiyang Zhou, Alison A. McCormick, Philip Thi, Payal D. Maharaj, Jyothi K. Mallajosyula
Publikováno v:
Journal of Advanced Biotechnology and Bioengineering. 2:49-59
Flock House virus (FHV) encodes a viral polymerase supporting autonomous replication of the FHV genome which makes it an attractive candidate for viral transgene expression studies and targeted RNA delivery into host cells. As FHV viral genome size i
Autor:
Yiyang Zhou, Christopher M. Kearney, Phillip Thi, Alison A. McCormick, Payal D. Maharaj, Gloria Lee, Jyothi K. Mallajosyula
Publikováno v:
International Journal of Molecular Sciences
Volume 15
Issue 10
Pages 18540-18556
International Journal of Molecular Sciences, Vol 15, Iss 10, Pp 18540-18556 (2014)
Volume 15
Issue 10
Pages 18540-18556
International Journal of Molecular Sciences, Vol 15, Iss 10, Pp 18540-18556 (2014)
Tobacco Mosaic virus (TMV) coat protein is well known for its ability to self-assemble into supramolecular nanoparticles, either as protein discs or as rods originating from the ~300 bp genomic RNA origin-of-assembly (OA). We have utilized TMV self-a
Autor:
Hugh Haydon, Richard J. Webby, Alison A. McCormick, Rachel Chikwamba, Trushar Jeevan, Ernie Hiatt, Barry Bratcher, Gregory P. Pogue, Steve Hume, Jyothi K. Mallajosyula, Ashley K. Johnson
Publikováno v:
Human Vaccines & Immunotherapeutics. 10:586-595
Recombinant subunit vaccines are an efficient strategy to meet the demands of a possible influenza pandemic, because of rapid and scalable production. However, vaccines made from recombinant hemagglutinin (HA) subunit protein are often of low potency